COMP <GO>
AMRN vs ABEO // GROSS PROFIT MARGIN
Amarin Corporation plc (NASDAQ) VS. Abeona Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: AMRN 6
— ABEO 1
▲ GROSS PROFIT MARGIN LEADER: ABEO
LAST: $12.74 (-0.08%) • MKT CAP: $262.8M
gross-margins
56.60%
LAST: $4.56 (+0.22%) • MKT CAP: $260.8M
gross-margins
73.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMRN VS. ABEO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMRN | ABEO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 56.60% | 73.70% | -17.10 | ABEO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.20% | -35.00% | +22.80 | AMRN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.56% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -23.50% | -60.00% | +36.50 | AMRN | /operating-margins <GO> |
| Net Profit Margin | -18.20% | -60.00% | +41.80 | AMRN | /net-margins <GO> |
| Revenue Growth (YoY) | -6.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 3/9 | +3.00 | AMRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.6 | 36.1 | +10.58 | AMRN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $262.8M | $260.8M | $2.0M | AMRN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMRN REV | ABEO REV | AMRN GROSS % | ABEO GROSS % | AMRN FCF | ABEO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $213.6M | $5.8M | 56.6% | 73.7% | $6.7M | -$84.3M |
| FY 2024 | $228.6M | $0 | 35.6% | — | -$31.0M | -$58.5M |
| FY 2023 | $306.9M | $3.5M | — | — | $6.9M | -$37.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMRN // BETA —
ABEO // BETA —